Honglei Yin

Zibo, 255300, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Retraction notice to "MicroRNA-128 knockout inhibits the development of Alzheimer's disease by targeting PPAR? In mouse models" [Eur. J. Pharmacol. 843 (2018) 134-144].

Retraction notice to "MicroRNA-128 knockout inhibits the development of Alzheimer's disease by targeting PPAR? In mouse models" [Eur. J. Pharmacol. 843 (2018) 134-144].

Journal: European journal of pharmacology

Published: March 05, 2025

The efficacy and safety of NeuroWell antidepressant dietary supplement, Deanxit, and their combination in the treatment of mild-to-moderate depression: A randomized clinical trial.

The efficacy and safety of NeuroWell antidepressant dietary supplement, Deanxit, and their combination in the treatment of mild-to-moderate depression: A randomized clinical trial.

Journal: Genes & diseases

Published: June 28, 2023

A focused transcriptomic analysis of the TP53-regulated genes identifies the GPI-anchored molecule-like protein (GML) as a favorable prognostic predictor of lung cancer.

A focused transcriptomic analysis of the TP53-regulated genes identifies the GPI-anchored molecule-like protein (GML) as a favorable prognostic predictor of lung cancer.

Journal: Genes & diseases

Published: February 10, 2022

Down-regulated long non-coding RNA RMST ameliorates dopaminergic neuron damage in Parkinson's disease rats via regulation of TLR/NF-κB signaling pathway.

Down-regulated long non-coding RNA RMST ameliorates dopaminergic neuron damage in Parkinson's disease rats via regulation of TLR/NF-κB signaling pathway.

Journal: Brain research bulletin

Published: September 01, 2020

Up-regulated microRNA-218-5p ameliorates the damage of dopaminergic neurons in rats with Parkinson's disease via suppression of LASP1.

Up-regulated microRNA-218-5p ameliorates the damage of dopaminergic neurons in rats with Parkinson's disease via suppression of LASP1.

Journal: Brain research bulletin

Published: March 20, 2020

MicroRNA-129-5p alleviates nerve injury and inflammatory response of Alzheimer's disease via downregulating SOX6.

MicroRNA-129-5p alleviates nerve injury and inflammatory response of Alzheimer's disease via downregulating SOX6.

Journal: Cell cycle (Georgetown, Tex.)

Published: October 01, 2019

MicroRNA-128 knockout inhibits the development of Alzheimer's disease by targeting PPARγ in mouse models.

MicroRNA-128 knockout inhibits the development of Alzheimer's disease by targeting PPARγ in mouse models.

Journal: European journal of pharmacology

Published: August 13, 2018

Relationship of polymorphisms and haplotype in interleukin-16 and adiponectin gene with late-onset Alzheimer's disease risk.

Relationship of polymorphisms and haplotype in interleukin-16 and adiponectin gene with late-onset Alzheimer's disease risk.

Journal: Oncotarget

Published: January 10, 2017

Gene- gene interaction between CYP2J2 and PPAR -γ gene on late-onset Alzheimer's disease in the eastern Chinese Han population.

Gene- gene interaction between CYP2J2 and PPAR -γ gene on late-onset Alzheimer's disease in the eastern Chinese Han population.

Journal: Behavioural brain research

Published: March 03, 2016

Effects of caffeic acid on learning deficits in a model of Alzheimer's disease.

Effects of caffeic acid on learning deficits in a model of Alzheimer's disease.

Journal: International journal of molecular medicine

Published: August 31, 2015

Elevated DRD4 promoter methylation increases the risk of Alzheimer's disease in males.

Elevated DRD4 promoter methylation increases the risk of Alzheimer's disease in males.

Journal: Molecular medicine reports

Published: August 14, 2015

CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling.

CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling.

Journal: Cancer letters

Published: February 10, 2015

Showing 1-12 of 19

Last Updated: 09/26/2026